Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004

Pediatrics

Volumn 118, Issue 3, 2006, Pages

  Moore, Dorothy L ^a   Vaudry, Wendy ^b   Scheifele, David W ^c   Halperin, Scott A ^d   Déry, Pierre ^e   Ford Jones, Elizabeth ^f   Arishi, Haider M ^g   Law, Barbara J ^g   Lebel, Marc ^h   Le Saux, Nicole ⁱ   Grimsrud, Karen ^j   Tam, Theresa ^k  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^j Provincial Health Office   (Canada)

^k PUBLIC HEALTH AGENCY OF CANADA   (Canada)

more..

Author keywords

Influenza; Pediatrics; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE; ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DISEASE; CANADA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CENTER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFLUENZA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; MYOCARDITIS; PATIENT MONITORING; PRIORITY JOURNAL; CHRONIC DISEASE; HEALTH SURVEY; INFANT; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTENSIVE CARE UNIT; LENGTH OF STAY; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; ANTIBODIES; CANADA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; PATIENT ADMISSION; POPULATION SURVEILLANCE; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 33749077793     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2744     Document Type: Article

References (41)

1. Wright PF, Ross KB, Thompson J, Karzon DT. Influenza A infections in young children: primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med. 1977;296:829-834
2. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978;298:587-592
3. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25 year prospective study. J Infect Dis. 2002;185:147-152
4. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239
5. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of influenza on hospitalizations, outpatient visits and courses of antibiotics in children. N Engl J Med. 2000;342:225-231
6. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-1340
7. Griffin MR, Walker FJ, Iwane MK, et al. New Vaccine Surveillance Network Study Group. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr Infect Dis J. 2004;23(suppl):S188-S192
8. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499-505
9. Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis. 2003;36:299-305
10. Quach C, Piche-Walker L, Platt R, Moore D. Risk Factors associated with severe influenza infections in childhood: implication for vaccine strategy. Pediatrics. 2003;112(3). Available at: www.pediatrics.org/cgi/content/ full/112/3/e197
11. Chiu SS, Tse CYC, Lau YL, Peiris M. Influenza A infection is an important cause of febrile seizures. Pediatrics. 2001;108(4). Available at: www.pediatrics.org/cgi/content/full/108/4/e63
12. Morishima T, Togashi T, Yokota S, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35:512-517
13. Togashi T, Matsuzono Y, Narita M, Morishima T. Influenza-associated acute encephalopathy in Japanese children in 1994-2002. Virus Res. 2004;103:75-78
14. Podewils LJ, Liedtke LA, McDonald LC, et al. A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis. 2005;40:1693-1696
15. Bridges CB, Harper SA, Fukuda K, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 2003;52:526]. MMWR Recomm Rep. 2003;52(RR-8):1-34; quiz CE1-4
16. Scheifele DW, Halperin SA, and Members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program, Active (IMPACT). Immunization Monitoring Program, Active, IMPACT: a model of active surveillance of vaccine safety. Semin Pediatr Infect Dis. 2003;14:213-219
17. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season. Can Commun Dis Rep. 2003;29:1-20
18. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA. 2005;294:2188-2194
19. Centers for Disease Control and Prevention. Update: Influenza-associated deaths reported among children aged <18 years - United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep. 2004;52:1286-1288
20. Vaudry W, Roth A, Lee B, Spady D. Active surveillance for influenza infection in children; Stollery Children's Hospital, 2003-4 season. Can Commun Dis Rep. 2004;30:157-164
21. Daley AJ, Nallusamy R, Isaacs D. Comparison of influenza A and influenza B virus infection in hospitalized children. J Paediatr Child Health. 2000;36:332-335
22. Maricich SM, Neul JL, Lotze TE, et al. Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics. 2004;114(5). Available at: www.pediatrics.org/cgi/content/full/114/5/e626
23. MacDonald KL, Osterholm MT, Hedberg CW, et al. Toxic shock syndrome. A newly recognized complication of influenza and influenza-like illness. JAMA. 1987;257:1053-1058
24. O'Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. 2000;30:784-789
25. Jensen ES, Lundbye-Christensen S, Samuelsson S, Sorensen HT, Schonheyder HC. A 20-year ecological study of the temporal association between influenza and meningococcal disease. Eur J Epidemiol. 2004;19:181-187
26. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season. Can Commun Dis Rep. 2004;30:1-32
27. Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis. 2004;190:1369-1373
28. Hemingway CO, Poehling KA. Change in recommendation affects influenza vaccinations among children 6 to 59 months of age. Pediatrics. 2004;114:948-952
29. Poehling KA, Speroff T, Dittus RS, Griffin MR, Hickson GB, Edwards KM. Predictors of influenza virus vaccination status in hospitalized children. Pediatrics. 2001;108(6). Available at: www.pediatrics.org/cgi/content/ full/108/6/e99
30. Grant VJ, Le Saux N, Plint AC et al. Factors influencing childhood influenza immunization. CMAJ. 2003;168:39-41
31. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 2005;54:750]. MMWR Recomm Rep. 2005;54(RR-8):1-40
32. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2005-2006 season. Can Commun Dis Rep. 2005;31:1-32
33. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep. 2004;53:743]. MMWR Recomm Rep. 2004;53(RR-6):1-40
34. American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for influenza immunization of children. Pediatrics. 2004;113:1441-1447
35. Rennels MB, Meissner HC; American Academy of Pediatrics, Committee on Infectious Diseases. Technical report: reduction of the influenza burden in children. Pediatrics. 2002;110(6). Available at: www.pediatrics.org/cgi/ content/full/110/6/e80
36. Ruben FL. Inactivated influenza virus vaccines in children. Clin Infect Dis. 2004;38:678-688
37. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J. 2004;23:189-250
38. Jefferson T, Smith S, Demicheli V, Hamden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet. 2005;365:773-780
39. Hoberman A, Greenberg DP, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003;290:1608-1616
40. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics. 2005;116:153-159
41. Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics. 1991;87:823-828